Brands are built by marketers, consumers, communities, and leaders. But the same people can also dismantle a brand, and when consumers and communities begin to organize against one, I call that an interest group. Brands that court controversy or earn it for whatever...
This month’s healthcare landscape is characterized by significant regulatory and technological milestones, showing a vibrant mix of challenges and advances in medical science and patient care. Advances in AI, like healthcare assistants and drug trials, lead the...
As the echoes of Miami’s Spring Break crackdown reverberate through the headlines, it’s clear that the city’s efforts to rein in the festivities have sparked a multifaceted discussion on the intersection of public safety and tourism. Headlined by...
It’s that time of year again: The time of year where all our favorite PR and communications organizations and event planners are frantically preparing for this year’s conference season. (Or in the case of a few events that have already taken place in 2024, they’re...
Miami is no stranger to the frenzy of Spring Break. However, in a surprising move, the city seems to be reevaluating its relationship with this iconic event. With headlines buzzing about Miami’s decision to distance itself from Spring Break, let’s dive into the...
In this edition of our pharma newsletter, we dive into a series of groundbreaking developments reshaping the landscape of healthcare and technology. With government actions poised to enhance drug affordability and accessibility and technological innovations pushing...
